Verfahren zur Inaktivierung von Viren
A process (I) for the treatment of a plasma protein solution to inactivate and/or eliminate enveloped and/or nonenveloped viruses comprising precipitating viruses with an ammonium salt, is new. A process (I) for treating a plasma protein solution to inactivate and/or eliminate enveloped and/or nonen...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | KUMPE, GERHARD NOWAK, THOMAS SCHUELER, ECKHARD |
description | A process (I) for the treatment of a plasma protein solution to inactivate and/or eliminate enveloped and/or nonenveloped viruses comprising precipitating viruses with an ammonium salt, is new. A process (I) for treating a plasma protein solution to inactivate and/or eliminate enveloped and/or nonenveloped viruses comprises: (a) incubating the solution with 13-22 wt.% of an ammonium salt at room temperature and alkaline pH; (b) removing the precipitate; (c) removing the ammonium salt to reduce the residual ammonium salt concentration to less than 0.5 mole/liter; (d) pasteurizing the solution at about 60 degrees C for several hours; and (e) processing the solution to obtain a therapeutically usable plasma protein preparation. Independent claims are also included for the following: (1) a process (II) for treating a plasma protein solution to inactivate and/or eliminate enveloped and/or nonenveloped viru comprising: (a) incubating the solution with 13-22 wt.% of an ammonium salt at room temperature and alkaline pH; (b) removing the precipitate; (c) increasing the ammonium salt concentration to 24-27 wt.%; (d) incubating the solution again; (e) collecting the resulting virus-free precipitate; (f) removing the ammonium salt to reduce the residual ammonium salt concentration to less than 0.5 mole/liter; (g) pasteurizing the precipitate at about 60 degrees C for several hours; and (h) processing the precipitate to obtain a therapeutically usable plasma protein preparation; and (2) a plasma protein preparation obtainable by process (I) or (II). |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DE19923027C2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DE19923027C2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DE19923027C23</originalsourceid><addsrcrecordid>eNrjZFANSy1KS8woSs1TqCotUvDMS8wuySzLTC0qzUtXKMvPUwjLBMrxMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JJ4F1dDS0sjYwMjc2cjY2LUAABMTic_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Verfahren zur Inaktivierung von Viren</title><source>esp@cenet</source><creator>KUMPE, GERHARD ; NOWAK, THOMAS ; SCHUELER, ECKHARD</creator><creatorcontrib>KUMPE, GERHARD ; NOWAK, THOMAS ; SCHUELER, ECKHARD</creatorcontrib><description>A process (I) for the treatment of a plasma protein solution to inactivate and/or eliminate enveloped and/or nonenveloped viruses comprising precipitating viruses with an ammonium salt, is new. A process (I) for treating a plasma protein solution to inactivate and/or eliminate enveloped and/or nonenveloped viruses comprises: (a) incubating the solution with 13-22 wt.% of an ammonium salt at room temperature and alkaline pH; (b) removing the precipitate; (c) removing the ammonium salt to reduce the residual ammonium salt concentration to less than 0.5 mole/liter; (d) pasteurizing the solution at about 60 degrees C for several hours; and (e) processing the solution to obtain a therapeutically usable plasma protein preparation. Independent claims are also included for the following: (1) a process (II) for treating a plasma protein solution to inactivate and/or eliminate enveloped and/or nonenveloped viru comprising: (a) incubating the solution with 13-22 wt.% of an ammonium salt at room temperature and alkaline pH; (b) removing the precipitate; (c) increasing the ammonium salt concentration to 24-27 wt.%; (d) incubating the solution again; (e) collecting the resulting virus-free precipitate; (f) removing the ammonium salt to reduce the residual ammonium salt concentration to less than 0.5 mole/liter; (g) pasteurizing the precipitate at about 60 degrees C for several hours; and (h) processing the precipitate to obtain a therapeutically usable plasma protein preparation; and (2) a plasma protein preparation obtainable by process (I) or (II).</description><edition>7</edition><language>ger</language><subject>BEER ; BIOCHEMISTRY ; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020919&DB=EPODOC&CC=DE&NR=19923027C2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020919&DB=EPODOC&CC=DE&NR=19923027C2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KUMPE, GERHARD</creatorcontrib><creatorcontrib>NOWAK, THOMAS</creatorcontrib><creatorcontrib>SCHUELER, ECKHARD</creatorcontrib><title>Verfahren zur Inaktivierung von Viren</title><description>A process (I) for the treatment of a plasma protein solution to inactivate and/or eliminate enveloped and/or nonenveloped viruses comprising precipitating viruses with an ammonium salt, is new. A process (I) for treating a plasma protein solution to inactivate and/or eliminate enveloped and/or nonenveloped viruses comprises: (a) incubating the solution with 13-22 wt.% of an ammonium salt at room temperature and alkaline pH; (b) removing the precipitate; (c) removing the ammonium salt to reduce the residual ammonium salt concentration to less than 0.5 mole/liter; (d) pasteurizing the solution at about 60 degrees C for several hours; and (e) processing the solution to obtain a therapeutically usable plasma protein preparation. Independent claims are also included for the following: (1) a process (II) for treating a plasma protein solution to inactivate and/or eliminate enveloped and/or nonenveloped viru comprising: (a) incubating the solution with 13-22 wt.% of an ammonium salt at room temperature and alkaline pH; (b) removing the precipitate; (c) increasing the ammonium salt concentration to 24-27 wt.%; (d) incubating the solution again; (e) collecting the resulting virus-free precipitate; (f) removing the ammonium salt to reduce the residual ammonium salt concentration to less than 0.5 mole/liter; (g) pasteurizing the precipitate at about 60 degrees C for several hours; and (h) processing the precipitate to obtain a therapeutically usable plasma protein preparation; and (2) a plasma protein preparation obtainable by process (I) or (II).</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>DISINFECTION, STERILISATION, OR DEODORISATION OF AIR</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFANSy1KS8woSs1TqCotUvDMS8wuySzLTC0qzUtXKMvPUwjLBMrxMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JJ4F1dDS0sjYwMjc2cjY2LUAABMTic_</recordid><startdate>20020919</startdate><enddate>20020919</enddate><creator>KUMPE, GERHARD</creator><creator>NOWAK, THOMAS</creator><creator>SCHUELER, ECKHARD</creator><scope>EVB</scope></search><sort><creationdate>20020919</creationdate><title>Verfahren zur Inaktivierung von Viren</title><author>KUMPE, GERHARD ; NOWAK, THOMAS ; SCHUELER, ECKHARD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DE19923027C23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2002</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>DISINFECTION, STERILISATION, OR DEODORISATION OF AIR</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>KUMPE, GERHARD</creatorcontrib><creatorcontrib>NOWAK, THOMAS</creatorcontrib><creatorcontrib>SCHUELER, ECKHARD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KUMPE, GERHARD</au><au>NOWAK, THOMAS</au><au>SCHUELER, ECKHARD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Verfahren zur Inaktivierung von Viren</title><date>2002-09-19</date><risdate>2002</risdate><abstract>A process (I) for the treatment of a plasma protein solution to inactivate and/or eliminate enveloped and/or nonenveloped viruses comprising precipitating viruses with an ammonium salt, is new. A process (I) for treating a plasma protein solution to inactivate and/or eliminate enveloped and/or nonenveloped viruses comprises: (a) incubating the solution with 13-22 wt.% of an ammonium salt at room temperature and alkaline pH; (b) removing the precipitate; (c) removing the ammonium salt to reduce the residual ammonium salt concentration to less than 0.5 mole/liter; (d) pasteurizing the solution at about 60 degrees C for several hours; and (e) processing the solution to obtain a therapeutically usable plasma protein preparation. Independent claims are also included for the following: (1) a process (II) for treating a plasma protein solution to inactivate and/or eliminate enveloped and/or nonenveloped viru comprising: (a) incubating the solution with 13-22 wt.% of an ammonium salt at room temperature and alkaline pH; (b) removing the precipitate; (c) increasing the ammonium salt concentration to 24-27 wt.%; (d) incubating the solution again; (e) collecting the resulting virus-free precipitate; (f) removing the ammonium salt to reduce the residual ammonium salt concentration to less than 0.5 mole/liter; (g) pasteurizing the precipitate at about 60 degrees C for several hours; and (h) processing the precipitate to obtain a therapeutically usable plasma protein preparation; and (2) a plasma protein preparation obtainable by process (I) or (II).</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | ger |
recordid | cdi_epo_espacenet_DE19923027C2 |
source | esp@cenet |
subjects | BEER BIOCHEMISTRY CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA DISINFECTION, STERILISATION, OR DEODORISATION OF AIR ENZYMOLOGY HUMAN NECESSITIES HYGIENE MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES MEDICAL OR VETERINARY SCIENCE METALLURGY METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
title | Verfahren zur Inaktivierung von Viren |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T06%3A32%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KUMPE,%20GERHARD&rft.date=2002-09-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDE19923027C2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |